Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis: A Multicenter Double-Blind Randomized Controlled Trail

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left"> </td><td align="center">Patients (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Mean age (yr)</td><td align="center">50.91 ± 8.36</td></tr><tr><td align="left">Male (%)</td><td align="center">124 (68.89)</td></tr><tr><td align="left">Female (%)</td><td align="center">56 (31.11)</td></tr><tr><td align="left">Child-Pugh classification</td><td align="center"> </td></tr><tr><td align="left"> A</td><td align="center">149 (82.78)</td></tr><tr><td align="left"> B</td><td align="center">28 (15.56)</td></tr><tr><td align="left"> C</td><td align="center">3 (1.67)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Clinical data of patients with CHB-caused cirrhosis.

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis: A Multicenter Double-Blind Randomized Controlled Trail 

Table 2 | Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis: A Multicenter Double-Blind Randomized Controlled Trail 